More than 4,000 doses of the Moderna COVID-19 vaccine on their way to Maine may need to be discarded because they did not arrive frozen. Moderna’s vaccine must be kept at -13°F to 5°F to ensure viability. Maine public health officials note…

Preliminary data on the CoronaVac—a COVID-19 vaccination manufactured by the Beijing-based biopharmaceutical company Sinovac—demonstrated only about 50% efficacy in preventing mild and severe COVID-19 illness in a Brazilian clinical trial.…

Tedros Adhanom Ghebreyesu, PhD—director-general of the World Health Organization (WHO)—criticized vaccine manufacturers for putting profits above ethics when it comes to equitably distributing COVID-19 immunizations. In an executive board…

With more than 2 million deaths attributed to COVID-19 across the world, public health officials are desperate to reduce the spread of the novel coronavirus while increasing vaccination rates. Some health experts have suggested that wearing…

As the United States struggles to get as many people vaccinated as quickly as possible, states have begun adjusting their priority policies. In New Jersey, all those age 65 and older and individuals between the ages of 16 and 64 with…

Two more contagious strains of the novel coronavirus have been identified in the United Kingdom and South Africa, but the United States has a chance to reduce their transmission here. While the strains (B117 from the UK, and 501Y.V2 or…

Personal protective equipment (PPE) for oral health professionals is no longer in short supply, according to the Organization for Safety, Asepsis and Prevention (OSAP). PPE—such as surgical masks, respirators, and disposable gowns—is…

During a January 12 press conference, United States Secretary of Health and Human Services Alex M. Azar II announced changes to the nation’s COVID-19 vaccine distribution policy in order to ensure more Americans receive the immunizations as…

Johnson & Johnson (J&J) may publish data from its COVID-19 vaccine’s Phase 3 clinical trial as early as the end of January. The 45,000 subject study began on December 17, 2020. If the results demonstrate the vaccine’s safety and…

In an examination of patients who have recovered from COVID-19, researchers found that severity of initial illness did not appear to correlate with the presence of lingering fatigue, ill health, or breathlessness. Published in the Annals of…